New ulcerative colitis drug goes Head-to-Head with standard treatment

NCT ID NCT06570772

Terminated Disease control Sponsor: Alvotech Swiss AG Source: ClinicalTrials.gov ↗

Summary

This study aimed to see if a new drug called AVT16 works as well as the existing drug Entyvio for controlling moderate to severe ulcerative colitis. It involved about 300 adults and directly compared the two treatments over a year. The study was designed to be fair, with neither the patients nor the doctors knowing which drug was being given.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Investigational Site 160101

Sliven, Bulgaria
Investigational Site 160102

Pleven, Bulgaria
Investigational Site 160103

Sofia, Bulgaria
Investigational Site 160105

Sofia, Bulgaria
Investigational Site 160106

Vratsa, Bulgaria
Investigational Site 160107

Stara Zagora, Bulgaria
Investigational Site 160108

Sofia, Bulgaria
Investigational Site 160109

Rousse, Bulgaria
Investigational Site 160111

Burgas, Bulgaria
Investigational Site 160202

Osijek, Croatia
Investigational Site 160202

Zagreb, Croatia
Investigational Site 160204

Bjelovar, Croatia
Investigational Site 160205

Rijeka, Croatia
Investigational Site 160206

Slavonski Brod, Croatia
Investigational Site 160207

Zagreb, Croatia
Investigational Site 160401

Chernivtsi, Ukraine
Investigational Site 160403

Vinnytsia, Ukraine
Investigational Site 160404

Kyiv, Ukraine
Investigational Site 160405

Kyiv, Ukraine
Investigational Site 160406

Kyiv, Ukraine
Investigational Site 160407

Lviv, Ukraine
Investigational Site 160408

Uzhhorod, Ukraine
Investigational Site 160409

Lviv, Ukraine
Investigational Site 160410

Vinnytsia, Ukraine
Investigational Site 160411

Cherkasy, Ukraine
Investigational Site 160412

Ivano-Frankivsk, Ukraine
Investigational Site 160413

Kyiv, Ukraine
Investigational Site 160415

Vinnytsia, Ukraine
Investigational Site 160416

Kyiv, Ukraine
Investigational Site 160417

Lviv, Ukraine
Investigational Site 160419

Zhytomyr, Ukraine
Investigational Site 160420

Kyiv, Ukraine
Investigational Site 160421

Vinnytsia, Ukraine
Investigational Site 160422

Kyiv, Ukraine
Investigational Site 160424

Vinnytsia, Ukraine
Investigational Site 160425

Kyiv, Ukraine
Investigational Site 160501

Tbilisi, Georgia
Investigational Site 160502

Tbilisi, Georgia
Investigational Site 160503

Tbilisi, Georgia
Investigational Site 160505

Tbilisi, Georgia
Investigational Site 160506

Tbilisi, Georgia
Investigational Site 160507

Batumi, 6010, Georgia
Investigational Site 160801

Riga, Latvia
Investigational Site 160802

Liepāja, Latvia
Investigational Site 160803

Riga, Latvia
Investigational Site 161005

Torun, Poland
Investigational Site 161006

Wroclaw, Poland
Investigational Site 161007

Warsaw, Poland
Investigational Site 161008

Chojnice, Poland
Investigational Site 161009

Sopot, Poland
Investigational Site 161010

Szczecin, Poland
Investigational Site 161012

Warsaw, Poland
Investigational Site 161013

Grudziądz, Poland
Investigational Site 161014

Swidnica, Poland
Investigational Site 161015

Lublin, Poland
Investigational Site 161016

Warsaw, Poland
Investigational Site 161017

Tychy, Poland
Investigational Site 161018

Knurów, Poland
Investigational Site 161021

Piotrkow Trybunalski, Poland
Investigational Site 161022

Poznan, Poland
Investigational Site 161023

Rzeszów, Poland
Investigational Site 161024

Rzeszów, Poland
Investigational Site 161025

Bydgoszcz, Poland
Investigational Site 161026

Zamość, Poland
Investigational Site 161028

Kłodzko, Poland
Investigational Site 161029

Kielce, Poland
Investigational Site 161033

Olsztyn, Poland
Investigational Site 161035

Krakow, Poland
Investigational Site 161037

Lodz, Poland
Investigational Site 161040

Wroclaw, Poland
Investigational Site 161041

Warsaw, Poland
Investigational Site 161101

Timișoara, Romania
Investigational Site 161102

Constanța, Romania
Investigational Site 161103

Târgu Mureş, Romania
Investigational Site 161201

Belgrade, Serbia
Investigational Site 161202

Pančevo, Serbia
Investigational Site 161203

Belgrade, Serbia
Investigational Site 161204

Belgrade, Serbia
Investigational Site 161205

Leskovac, Serbia
Investigational Site 161206

Belgrade, Serbia
Investigational Site 161207

Novi Sad, Serbia
Investigational Site 161208

Zrenjanin, Serbia
Investigational Site 161209

Belgrade, Serbia
Investigational Site 161211

Niš, Serbia
Investigational Site 161301

Košice, Slovakia
Investigational Site 161302

Prešov, Slovakia
Investigational Site 161303

Bratislava, Slovakia
Investigational Site 161304

Banská Bystrica, Slovakia
Investigational Site 161305

Rimavská Sobota, Slovakia
Investigational Site 161306

Trnava, Slovakia
Investigational Site 1614011

Ksawerów, Poland
Investigational Site 161701

Quilmes, Argentina
Investigational Site 161702

Córdoba, Argentina
Investigational Site 161704

Ciudad Autónoma de BuenosAires, Argentina
Investigational Site 161705

San Miguel de Tucumán, Argentina
Investigational Site 162201

Ragama, Sri Lanka
Investigational Site 162203

Galle, Sri Lanka
Investigational Site 162204

Colombo, Sri Lanka
Investigational Site 162205

Kandy, Sri Lanka
Investigational Site 162206

Jaffna, Sri Lanka

Conditions

Explore the condition pages connected to this study.

ULCERATIVE COLITIS